Spravato Treatment

SPRAVATO®, the only FDA-approved nasal spray for adult patients with two forms of challenging-to-treat major depressive disorder (MDD):

  • Adults with MDD who’ve had an inadequate response to two or more oral antidepressants, known as treatment-resistant depression (TRD)

  • Depressive symptoms in adults with MDD with suicidal thoughts or actions (MDSI)

 

SPRAVATO® is an adjunctive treatment option for adults with treatment-resistant depression or depressive symptoms in adults with major depression and acute suicidal ideation or behavior.  Reach out to us today to explore if this treatment can be beneficial for you.

Our team is here to provide guidance and support on

your journey towards improved mental health.

 

Reference

https://www.spravato.com/

https://www.fda.gov